This HTML5 document contains 72 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n12	http://dx.doi.org/10.1021/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q58199067

rdf:type

wikibase:Item

schema:description

наукова стаття, опублікована в жовтні 2012 artículu científicu espublizáu n'ochobre de 2012 im Oktober 2012 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel scientific article published on 22 October 2012

p:P577

wds:Q58199067-5B4AE62E-ACAC-4B53-B7D8-165E2D0EF6C1

wdt:P577

2012-10-22T00:00:00Z

p:P407

wds:Q58199067-974B1AA2-E412-4446-96BD-DDCBE1244422

wdt:P407

wd:Q1860

p:P2093

wds:Q58199067-41B8DCCC-D93D-4B4C-AD79-8C1AF01D0D9C wds:Q58199067-473E040D-7857-4419-99F9-E89809394A17 wds:Q58199067-3B383674-0C0F-41E2-BF39-A2A3111EED73 wds:Q58199067-3520C92B-CA5A-49CD-8419-20F7D57DC041 wds:Q58199067-38AD07FB-A2D8-43D5-A148-D9DA1AF77B70 wds:Q58199067-0D3740B5-F693-4F09-8C07-8DCE1672E3A7 wds:Q58199067-0A0C6632-20B7-4FF0-8435-20B5B318BA6F wds:Q58199067-FECB95B5-0470-4165-BCBC-5910A0187418 wds:Q58199067-BA59F4AB-59D8-4977-9CCE-656B5623E0B4 wds:Q58199067-BD7526DB-0B49-4F10-9B86-511C409C23D1 wds:Q58199067-AE8F347A-28BF-4933-BED0-95DF4DBC93DA wds:Q58199067-9C1013FE-A894-4182-8CFE-FC09EFD7E92E wds:Q58199067-96CA7247-888E-4E28-9A16-33D7AC509D32 wds:Q58199067-8D5765A2-0F4C-4550-8D3C-044BB8C0FEF8 wds:Q58199067-535A2779-ABAC-4EA4-BB46-C9968428018B

wdt:P2093

Karen Kleberg Philip Sassene Hassan Benameur Mario Maio Jean-Claude Bakala-N'Goma Mette U Anby Marilyn Calderone Vincent Jannin Eduardo Jule Anette Partheil Ross Blundell Jan Vertommen Annabel Igonin Hywel D Williams Delphine Marchaud

rdfs:label

Toward the Establishment of Standardized in Vitro Tests for Lipid-Based Formulations. 2. The Effect of Bile Salt Concentration and Drug Loading on the Performance of Type I, II, IIIA, IIIB, and IV Formulations during in Vitro Digestion Toward the Establishment of Standardized in Vitro Tests for Lipid-Based Formulations. 2. The Effect of Bile Salt Concentration and Drug Loading on the Performance of Type I, II, IIIA, IIIB, and IV Formulations during in Vitro Digestion

skos:prefLabel

Toward the Establishment of Standardized in Vitro Tests for Lipid-Based Formulations. 2. The Effect of Bile Salt Concentration and Drug Loading on the Performance of Type I, II, IIIA, IIIB, and IV Formulations during in Vitro Digestion Toward the Establishment of Standardized in Vitro Tests for Lipid-Based Formulations. 2. The Effect of Bile Salt Concentration and Drug Loading on the Performance of Type I, II, IIIA, IIIB, and IV Formulations during in Vitro Digestion

schema:name

Toward the Establishment of Standardized in Vitro Tests for Lipid-Based Formulations. 2. The Effect of Bile Salt Concentration and Drug Loading on the Performance of Type I, II, IIIA, IIIB, and IV Formulations during in Vitro Digestion Toward the Establishment of Standardized in Vitro Tests for Lipid-Based Formulations. 2. The Effect of Bile Salt Concentration and Drug Loading on the Performance of Type I, II, IIIA, IIIB, and IV Formulations during in Vitro Digestion

p:P50

wds:Q58199067-59AD6581-4773-49A4-A0EE-69901CE16855 wds:Q58199067-79719A68-26DF-4CEC-9A81-675C689747AC wds:Q58199067-A6CF1C4F-D4C5-4CC0-9BA6-88194D2D256E wds:Q58199067-C537CC58-FF0F-4DAF-99F3-DD8CA3E95252

wdt:P50

wd:Q37828565 wd:Q40729100 wd:Q62833120 wd:Q38804793

p:P1476

wds:Q58199067-39907C20-1ABB-47A0-9C52-0ECAF6D327E3

wdt:P1476

Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion

p:P304

wds:Q58199067-E57E04F6-92C4-4140-87D7-1FE80210D314

wdt:P304

3286-3300

p:P31

wds:Q58199067-3E18BC7A-53E6-4A19-8AF5-3BEC02E9EE22

wdt:P31

wd:Q13442814

p:P698

wds:Q58199067-A8F9C36F-E810-412D-A9C8-1F3E5E14E736

wdtn:P698

n10:23030411

wdt:P698

23030411

p:P1433

wds:Q58199067-3D6D4A7D-C79A-4E64-BD99-527F865C77B9

wdt:P1433

wd:Q3011140

p:P433

wds:Q58199067-79DFEED4-F4DA-4540-993B-79BFFE6373D8

p:P478

wds:Q58199067-D2F62F08-7382-421D-8E66-AAD78F269F90

wdt:P433

11

wdt:P478

9

p:P356

wds:Q58199067-297867E9-A081-43D4-9B30-734C15D3ECBB

wdtn:P356

n12:MP300331Z

wdt:P356

10.1021/MP300331Z